Caribou Biosciences (CRBU) Interest Expenses (2020 - 2026)
Caribou Biosciences (CRBU) posted quarterly Interest Expenses of $1.7 million for Q1 2026, up 5393.55% year-over-year from $31000.0 in Q1 2025, and up 265.45% quarter-over-quarter from $466000.0 in Q4 2025.
Caribou Biosciences (CRBU) Interest Expenses (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has reported Interest Expenses for 7 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 5393.55% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 5393.55% YoY), while the FY2025 annual figure was $186.9 million, up 26.87% from the prior year.
- Interest Expenses grew to $1.7 million in Q1 2026 per CRBU's latest filing, from $466000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $47.2 million in Q2 2022 and bottomed at $31000.0 in Q1 2025.
- Historically, Interest Expenses has averaged $13.8 million across 5 years, with a median of $1.7 million in 2026.
- Annual changes were most pronounced in 2025 — Interest Expenses plunged 99.92% — and 2026, when it soared 5393.55%.
- Caribou Biosciences' Interest Expenses stood at $1.0 million in 2022, then gained by 11.93% to $1.1 million in 2023, then dropped by 20.88% to $898000.0 in 2024, then tumbled by 48.11% to $466000.0 in 2025, then jumped by 265.45% to $1.7 million in 2026.
- Business Quant data shows CRBU's Interest Expenses at $1.7 million in Q1 2026, $466000.0 in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Caribou Biosciences | 166.63 Mn | 54.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 913,000.00 |
| Jun 30, 2026 | 913,000.00 |
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 466,000.00 |
| Dec 31, 2025 | 466,000.00 |
| Sep 30, 2025 | 3.05 Mn |
| Sep 30, 2025 | 3.05 Mn |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 898,000.00 |
| Dec 31, 2024 | 898,000.00 |
| Sep 30, 2024 | 38.97 Mn |
| Sep 30, 2024 | 38.97 Mn |
| Jun 30, 2024 | 13.09 Mn |
| Jun 30, 2024 | 13.09 Mn |
| Mar 31, 2024 | 41.01 Mn |
| Mar 31, 2024 | 41.01 Mn |